The AstraZeneca pharmaceutical group announced a global suspension of clinical trials for its experimental vaccine against Covid-19, given the appearance of complications in a program participant, it looks like a spinal problem. The group, associated withUniversity of Oxford, he did know that the protocol tripped in front of a adverse reaction serious and unexplainable and … Read more
The AstraZeneca pharmaceutical group announced a global suspension of clinical trials for its experimental vaccine against covid-19, given the appearance of complications in one program participant. The group, associated withOxford University, made it known that the protocol tripped in front of a potential adverse reaction and that the suspension was therefore autonomously decided to allow … Read more
AstraZeneca and the University of Oxford are pausing the study of the corona vaccine because a potentially serious side effect has occurred in one of the British subjects. This is evident from a statement that AstraZeneca to several media, including STAT News, AP en CNN, has sent. Brazil, one of the countries where AstraZeneca is … Read more
Jakarta, CNBC Indonesia – A number of pharmaceutical companies have started to reveal the price of the Covid-19 vaccine that is being developed. So which corona vaccine is the cheapest when it’s ready for public use? Until now, the most expensive price for the Covid-19 vaccine belongs to China National Pharmaceutical Group or Sinopharm. This … Read more
Illustration of corona virus vaccine (Source: Fresh Daily) KOMPAS.TV – Vaccines developed by AstraZeneca (AZN.L) and Moderna (MRNA.O) are the two strongest candidates for the official corona virus vaccine. This was conveyed by WHO Chief Scientist, Soumya Swaminathan, quoted from Reuters via Kompas.com, Friday (6/26/2020). According to Swaminathan, vaccines from AstraZeneca have made it possible … Read more
Brazil considers that the agreement by which it will have the technology to produce the coronavirus vaccine that is being experimented by the University of Oxford and the capacity of its laboratories will allow it to become the supplier of the immunizer for all of Latin America. The forecast is from the Oswaldo Cruz Foundation … Read more
Berlin According to an agency report, a megafusion could occur in the pharmaceutical industry. The British company Astra-Zeneca approached US biotech rival Gilead Sciences last month to sound out a possible merger, the Bloomberg news agency reported on Sunday, citing insiders. According to the report, there are still no formal talks about such a transaction. … Read more
The Anglo-Swedish company announced that it had received more than $ 1 billion from the American Authority for Advanced Research and Biomedical Development for the development, production and distribution of the vaccine, starting in the fall. The investment will accelerate the development and production of the vaccine, said AstraZeneca’s executive director, Pascal Soriot. “We will … Read more
<div id = "firstBodyDiv" data-bind-html-content-type = "article" data-bind-html-compile = "article.body" data-first-article-body = " The Anglo-Swedish company stated that it had received more than $ 1 billion from the American Advanced Biomedical Research and Development Authority to develop, produce and deliver the vaccine, starting next fall. The drug giant said it had already received a request … Read more
LONDON (Dow Jones) – Pharmaceutical company Astrazeneca also plans to use its blood cancer drug Calquence to treat Covid-19. For this purpose, the company now wants to test it on critically ill patients with an overreaction of the immune system. The tests are expected to take place at multiple locations in the United States and … Read more